Skip to content

Off-line bioartificial liver system in the treatment of liver failure patients

Off-line bioartificial liver system in the treatment of liver failure patients

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-12002029
Enrollment
Unknown
Registered
2012-02-29
Start date
2010-12-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver failure

Interventions

1:Plasma exchange
2:Plasma exchange + off-line plasma adsorption + Off-line bioartificial liver system

Sponsors

302 Military Hospital of China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Signed the informed consent form before participation; 2. Between 18 and 65 years old; 3. Acute, sub-acute, acute on chronic liver failure caused by various reasons, including virus, alcohol, drug or inherited metabolic disease.

Exclusion criteria

Exclusion criteria: 1. Primary or metastasis liver cancer; 2. Existence of uncontrolled severe infection; 3. Shock; 4. Active gastrointestinal bleeding; 5. Definite decompensate cirrhosis; 6. Existence of any other severe active physical or mental diseases; 7. Highly allergic to heparin, plasma or protamine; 8. Pregnancy or lactation.

Design outcomes

Primary

MeasureTime frame
liver function indicators;PTA;Urea;Creatinine;Survial Time and Survival Rate;

Countries

China

Contacts

Public ContactShaojie Xin
xsj302@yahoo.com.cn+86 10 66933434

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026